<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04002986</url>
  </required_header>
  <id_info>
    <org_study_id>19-004343</org_study_id>
    <nct_id>NCT04002986</nct_id>
  </id_info>
  <brief_title>Comprehensive Genetic Assessment, Risk and Education in a Mammography Pilot</brief_title>
  <official_title>Comprehensive Genetic Assessment, Risk and Education in a Mammography Pilot</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Researchers are trying to learn more about the prevalence of genetic mutations in women who
      are at intermediate/high risk of breast cancer and how that information my assist providers
      in improving screening and preventative options.
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">August 20, 2019</start_date>
  <completion_date type="Anticipated">December 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Genetic mutations</measure>
    <time_frame>One year</time_frame>
    <description>Number of subjects to have a pathogenic/likely pathogenic mutations (Positive test result on Proactive Cancer Screening Panel)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Study Participants</measure>
    <time_frame>One year</time_frame>
    <description>Number of subjects who decide to undergo genetic panel testing</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">250</enrollment>
  <condition>Women Age 35+ Qualifies if &gt;15% Lifetime Risk of Breast Cancer as Defined by IBIS Version 8</condition>
  <arm_group>
    <arm_group_label>Women at intermediate/high risk of breast cancer</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Women age 35 years old identified at intermediate/high risk of breast cancer will receive genetic testing</description>
  </arm_group>
  <intervention>
    <intervention_type>Genetic</intervention_type>
    <intervention_name>Genetic Testing</intervention_name>
    <description>A blood draw or saliva kit will be provided to collect subject cells</description>
    <arm_group_label>Women at intermediate/high risk of breast cancer</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Women participating in IRB:18-010601

          -  Aged 35 and over with a negative routine mammogram within 3 months.

          -  Qualifies as intermediate or high-risk (&gt;15% lifetime risk of breast cancer as defined
             by IBIS version 8).

          -  Have an active email address for survey completion

        Exclusion Criteria:

          -  Not participating in the Mayo Clinic CEDM pilot (IRB: 18-010601)

          -  Known genetic cancer syndrome with test results available for review in Mayo EMR

          -  Known breast cancer

          -  Unable to understand or sign informed consent
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>N. Jewel Samadder, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mayo Clinic in Arizona</name>
      <address>
        <city>Scottsdale</city>
        <state>Arizona</state>
        <zip>85259</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://www.mayo.edu/research/clinical-trials</url>
    <description>Mayo Clinic Clinical Trials</description>
  </link>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>June 27, 2019</study_first_submitted>
  <study_first_submitted_qc>June 27, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 1, 2019</study_first_posted>
  <last_update_submitted>February 25, 2020</last_update_submitted>
  <last_update_submitted_qc>February 25, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 27, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>Niloy Jewel (Jewel) Samadder</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>increased risk of breast cancer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

